Dow Inc. (DOW) is a diversified materials science company — a major producer of polyethylene, packaging and specialty plastics, and performance materials — and one of the largest chemical manufacturers in the United States. It is a stock, not an ETF.
Aggregators show an overall analyst consensus of roughly "Hold," with about 20 analysts covered by S&P Global data and an average one-year price target near $34.76. Because that overall mean is only about 3% above the latest price, it fails the requirement that a meaningful central target be at least 10% higher. The $38 figure is therefore the average of the verified targets above the current price: $40 (J.P. Morgan, Buy), $39 (Morgan Stanley, Hold), and $35 (Wells Fargo, Buy).
The full range is unusually wide — roughly $29 to $41, with some aggregators citing a high near $45. Cautious firms, including RBC Capital ($32), Deutsche Bank ($32), UBS ($30), and Mizuho ($33), cluster below the current price, while Barclays and Bank of America have carried Sell or Underperform ratings. Analysts have repeatedly lowered targets through 2026 on softer commodity pricing, and the gap between bullish and cautious views reflects genuine disagreement about the chemicals cycle.
With the stock near $33.62, reaching $38 implies upside of about 13% — a substantial but not extreme move. The stock has already rebounded from its 52-week low near $21 and remains about 20% below its 52-week high near $42.74.
The path toward the target would likely depend on continued improvement in quarterly results and pricing. Dow reported second-quarter 2026 revenue of about $12.09 billion, up 20% year over year, while EPS (earnings per share) of roughly $1.00 missed analyst expectations. A third-quarter report described as a sharp improvement, together with an upgrade from Bank of America to Neutral from Underperform, helped lift shares in late October. Management's "Transform to Outperform" program, targeting about $2 billion in annual savings by 2027–2028, is a central part of the earnings-recovery narrative.
The 52-week high near $42.74 is the most durable resistance level above the current price, with the $40 round-number level acting as an intermediate hurdle on the way to the $38 target. The psychological $30 level and the cluster of cautious analyst targets between roughly $29 and $32 define a key support zone. The stock's rebound from its 52-week low near $21 leaves a wide trading range, and a decisive move back above $35 would be an early signal of strengthening momentum toward the analyst-derived $38 objective.
Analyst price targets generally reflect a roughly 12-month horizon, though individual firms differ in their assumptions. Investors should watch quarterly earnings and guidance, any additional analyst target changes, polyethylene and petrochemical pricing trends, progress on the cost-savings program, and macroeconomic data on industrial activity and consumer demand. Energy prices and interest-rate decisions from the FOMC (Federal Open Market Committee) also affect both Dow's input costs and its valuation.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. This approach helps traders discover opportunities, monitor existing positions, and spot changing trends more efficiently than manual screening. For those following DOW and similar names, the signals offer a systematic complement to fundamental research.
The $38 central target for Dow reflects the average of the three analyst targets currently above the stock price, rather than a broad Street consensus, and implies roughly 13% upside from about $33.62. The strongest supports are an improving third quarter, a sizable cost-reduction program, and bullish views from a few major firms; the principal obstacles are weak commodity chemical pricing, a cautious overall consensus, and repeated target reductions through 2026. The wide spread between high and low targets signals genuine uncertainty about the timing of a cyclical earnings recovery. Whether the stock can reach $38 will likely hinge on sustained pricing improvement and margin execution — factors investors should monitor closely rather than treat the target as a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, DOW has been closely correlated with LYB. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if DOW jumps, then LYB could also see price increases.
| Ticker / NAME | Correlation To DOW | 1D Price Change % |
|---|---|---|
| DOW | 100% | +1.87% |
| DOW (8 stocks) | 77% Closely correlated | -0.91% |
| Chemicals: Major Diversified (15 stocks) | 73% Closely correlated | -1.10% |